"Avast ye hearties! The Islatravir Antiretroviral Trial be sunk, yieldin' no positive booty for all yer pillagin'!"
2023-08-04
Avast ye scurvy dogs! The gatherin' of crew members for the third trial o' the wondrous islatravir pill, taken once a day, alongside doravirine, has come to an end. But fret not, for the study on this new-fangled treatment for the dreaded HIV ailment carried on fer a full 48 weeks! Yo ho ho!
Arrr, me hearties! Listen up, ye scurvy dogs! I've got news for ye that'll shiver yer timbers! The recruitment for a grand and mighty phase 3 trial has come to a halt, but fear not, for the study on this newfangled treatment for the dreaded HIV continued for a full 48 weeks!Ahoy, me matey, what be this newfangled drug called? 'Tis a mouthful, I tell ye! They be callin' it islatravir, a once-daily oral medication that be combined with another fancy name called doravirine. They be testin' this concoction to see if it be helpin' those souls afflicted with the notorious HIV.
Now, why be they stoppin' the recruitment, ye ask? Well, it be a mystery to me, but I reckon they be gettin' enough swashbucklers and buccaneers to join their trial. But fear not, for the brave souls who volunteered be continuin' this grand adventure for the full 48 weeks! Aye, they be committed to findin' a new option to fight this disease that be plaguin' the seven seas.
Arrr, me hearties, this be news worth sharin'! The study, ye see, be conducted by some learned folks from the Medscape Medical News, who be keepin' a close eye on the progress of this investigational new option. They be wantin' to see if this islatravir mixed with doravirine be a match made in Davy Jones' locker, aye!
So, me fellow pirates, let us raise a tankard of grog to those brave souls who be sailin' through this trial. May their journey lead to a treasure trove of knowledge and a cure for the dreaded HIV! Yo ho ho and a bottle of rum!